|
| |
 |
|
| BASIC RESEARCH |
|
| Year : 2018 | Volume
: 8
| Issue : 3 | Page : 173-178 |
|
Synsepalum dulcificum extracts exhibit cytotoxic activity on human colorectal cancer cells and upregulate c-fos and c-jun early apoptotic gene expression
Jichang Seong1, Glenn G Oyong2, Esperanza C Cabrera2
1 Biology Department, De La Salle University, 2401 Taft Avenue, Manila 0922, Philippines
2 Biology Department, De La Salle University, 2401 Taft Avenue; Molecular Science Unit Laboratory, Center for Natural Science and Environmental Research, De La Salle University, 2401 Taft Avenue, Manila 0922, Philippines
| Date of Submission | 26-Nov-2017 |
| Date of Decision | 22-Dec-2017 |
| Date of Acceptance | 20-Jan-2018 |
| Date of Web Publication | 21-Mar-2018 |
Correspondence Address:
Esperanza C Cabrera
Biology Department, De La Salle University, 2401 Taft Avenue; Molecular Science Unit Laboratory, Center for Natural Science and Environmental Research, De La Salle University, 2401 Taft Avenue, Manila 0922
Philippines
 Source of Support: None, Conflict of Interest: None  | 11 |
DOI: 10.4103/2221-1691.227999
Objective: To explore cytotoxicity of Synsepalum dulcificum (S. dulcificum) Daniell (Sapotaceae) on human colon cancer (HCT-116 and HT-29), human monocytic leukemia (THP-1) and normal (HDFn) cell lines, and its effect on the expression of early apoptotic genes, c-fos and c-jun. Methods: Leaf, stem and berry of S. dulcificum were separately extracted by using 2 solvents, 10% ethanol (EtOH) and 80% methanol (MeOH). PrestoBlue® cell viability assay and qRT-PCR assay were conducted to examine the above objectives respectively. Results: Stem MeOH, stem EtOH, and berry EtOH extracts of S. dulcificum were cytotoxic to HCT-116 and HT-29 human colon cancer cells. For HCT-116, IC50 values of these 3 extracts were not significantly different (P>0.05) from that of the positive control bleomycin (IC50 of 33.57 μg/mL), while for HT-29, IC50 values of these 3 extracts were significantly lower (P<0.05) than that of bleomycin (IC50 of 25.24 μg/mL). None of the extracts were cytotoxic to the THP-1 monocytic leukemia cells and HDFn normal human dermal fibroblasts. For both HCT-116 and HT-29, these extracts significantly up-regulated (P<0.05) the expression of c-fos and c-jun compared to the untreated negative control. Conclusions: The results of this study suggest that cytotoxicity of stem MeOH, stem EtOH, and berry EtOH extracts of S. dulcificum on HCT-116 and HT-29 colon cancer cells is due to the induced apoptosis which is caused by the up-regulation of the expression of early apoptotic genes, c-fos and c-jun.
Keywords: Synsepalum dulcificum, Colon cancer, Monocytic leukemia, Apoptosis, c-fos, c-jun
How to cite this article:
Seong J, Oyong GG, Cabrera EC. Synsepalum dulcificum extracts exhibit cytotoxic activity on human colorectal cancer cells and upregulate c-fos and c-jun early apoptotic gene expression. Asian Pac J Trop Biomed 2018;8:173-8 |
How to cite this URL:
Seong J, Oyong GG, Cabrera EC. Synsepalum dulcificum extracts exhibit cytotoxic activity on human colorectal cancer cells and upregulate c-fos and c-jun early apoptotic gene expression. Asian Pac J Trop Biomed [serial online] 2018 [cited 2023 Mar 20];8:173-8. Available from: https://www.apjtb.org/text.asp?2018/8/3/173/227999 |
| 1. Introduction | |  |
Cancer is one of the major causes of death in both economically developed and developing countries[1],[2]. In 2012, about 14.1 million people were diagnosed with cancer and 8.2 million deaths due to cancer were reported[2]. It has been estimated that about 1.68 million people will be diagnosed with cancer and 595 690 deaths will occur due to cancer in 2016 in United States alone[3]. Among all types of cancer, colorectal cancer is the third leading cause of death in women and fourth in men[2]. Cancer originates from the uncontrolled cell proliferation and suppression of apoptosis[4],[5], an autonomous, genetically programmed cell death necessary for animal development and homeostasis of cell population[6],[7],[8]. Due to the enormous side effects which are brought together by the modern cancer therapies such as chemotherapy and radiotherapy, minimal side effect-causing methods, such as apoptosis induction through plant-derived anticancer agents, is being favored[9].
Synsepalum dulcificum (S. dulcificum) Daniell (Sapotaceae), which is popularly known as miracle fruit, is an ever-green shrub native in tropical west and west Central Africa. The miracle fruit is well known for its distinctive property of altering the tongue's reception of sour taste into sweet taste. This taste alteration is due to a protein called miraculin found in the berries[10],[11],[12]. Further studies on S. dulcificum revealed that the shrub not only possesses the ability to alter taste, but also possesses antioxidant, antibacterial, as well as anticancer activities[13],[14],[15],[16]. Du et al. reported that the flesh and seed extracts exhibited antioxidant property, wherein the flesh extract exhibited significantly more or similar potencies as antioxidant standards[13]. Other groups also reported that the leaf[14] and stem[15] extracts showed antioxidant activity. Furthermore, Lu et al. reported that the leaf essential oil showed antibacterial activity against common experimental bacteria such as Bacillus subtilis and Escherichia coli[l6]. Several groups showed that various part extracts of S. dulcificum exhibited anticancer activities on A375.S2 human melanoma cells[15], HepG2 human liver cancer cells[14], and K562 human myelogenous leukemia cells[16] in a dose-dependent manner.
Although the chemical compositions of all the parts of S. dulcificum are identified[13],[14],[15],[16],[17],[18],[19], and various effects of certain parts of the plant have been studied[13],[14],[15],[16], the bioactivities, especially cytotoxicity of the parts of S. dulcificum and the molecular mechanism on how the extracts exhibit cytotoxicity on different cancer cell lines need further studies. Thus, this study aimed to determine the cytotoxicity of S. dulcificum extracts on HCT-116 and HT-29 human colorectal cancer cells, THP-1 human monocytic leukemia cells, and HDFn normal human fibroblasts, and to determine the effect of plant extracts on the expression of the early apoptotic genes, c-fos and c-jun.
| 2. Materials and methods | | |
2.1. Plant material
S. dulcificum shrubs were obtained from the Agri-Aqua Network International, Inc. (AANI), Quezon City, Philippines. The identity of the shrub was authenticated by Dr. Emelina Mandia of the Biology Department, College of Science, De La Salle University, Manila.
2.2. Cell cultures
HCT-116 and HT-29 human colorectal cancer cells, and THP-1 human monocytic leukemia cells were previously procured from the American Type Culture Collection (USA), while HDFn human neonatal dermal fibroblasts were previously procured from Invitrogen (USA). The cell cultures were kindly provided by the Molecular Science Unit Laboratory of the Center for Natural Science and Environmental Research of De La Salle University, Manila. HCT-116, HT-29, and HDFn were cultured to 90% confluency in Dulbecco's Modified Eagle Medium (DMEM) (Gibco, USA) with 10% fetal bovine serum (Invitrogen, USA) and 1 × anti- mycotic antibiotic (Invitrogen, USA) in 50 mL T-flasks (Falcon, USA) at 37 °C in 95% humidity and 5% CO2 atmosphere. THP-1 was cultured to 90% confluence in Roswell Park Memorial Institute medium (Gibco, USA) with the same supplements and conditions as above. All cells were harvested by using 0.05% trypsin-EDTA (Gibco, USA) in phosphate buffered saline at pH 7.4 (Gibco, USA). All cells were harvested at their log phase.
2.3. Preparation of S. dulcificum extracts
The plant extracts were prepared following the methods of Du et al.[l3] with slight modifications. The leaves, stems, and berries of S. dulcificum were harvested and cleaned first with tap water and rinsed twice in sterile distilled water. Thereafter, cleaned plant materials were dried for 1 wk at room temperature. The extraction procedure was as follows: Ten grams of each powdered sample were separately mixed with 100 mL of freshly prepared 80% MeOH and 10% EtOH solvent for 24 h with stirring using a magnetic stirrer. The mixtures were then centrifuged at 4 500 rpm for 10 min, and the solvent layers were collected in individual flasks. Another 100 mL of freshly prepared solvents were separately added to the residues, and the same procedure was followed to extract once more. The two collected solvent layers were combined accordingly and evaporated through rotary evaporator (IKA® RV10, USA). The evaporated solutions were then lyophilized at -40 °C to get the dry extracts (LABIONIO Freeze dry system/freezone®4.5, USA). The dried extracts were diluted with 0.2% DMSO in phosphate buffered saline to the concentration of 1 g/mL.
2.4. Cell viability assay
All cell lines were subjected to viable cell counts by using Trypan blue exclusion method and adjusted to the cell density of 1.0 × 105 viable cells/mL. One hundred microliters of each cell line were independently dispensed into sterile 96-well plates (Falcon, USA) resulting in 1.0 × 104 cells/well, and incubated for 24 h to allow the cells to attach and form monolayers on the bottom of the wells. The test extracts were freshly prepared by diluting the crude extracts to a concentration of 200 μg/mL using 0.2% DMSO in complete DMEM as vehicle solvent and filter-sterilized by using 0.45 μm membrane filter (Millipore, USA). The extracts were applied to the respective wells following 2-fold serial dilution. For positive control, bleomycin at a concentration of 200 μg/mL was added into the respective wells, and 2-fold serial dilution was likewise conducted. For vehicle control, 2 rows of wells with cells were grown in complete DMEM with 0.2% DMSO. For negative control, another 2 rows of wells with cells were grown in complete DMEM and left untreated. Thereafter, the plates were incubated for a week and the applied plant extracts were removed from the well. The wells were washed with phosphate buffered saline to remove the pigments of the extracts, and 100 μL of fresh complete DMEM were added. Each well was added with 10 μL of PrestoBlue® resazurin reagent (Invitrogen, USA), and re-incubated as before for 4 h. Absorbance measurement was accomplished at 570 nm in a microplate reader (Biotek EL × 800, BioTek Instruments, USA). Percent cell death from each treatment concentration was derived using the following formula[20]:
% cell death=100-[(Absorbance of sample/Absorbance of negative control) × 100]
Cytotoxicity graphs were constructed by plotting the % cell death against plant extract treatment concentration μg/mL). Cytotoxicity index affecting 50% of the cells (IC50) were derived from the cytotoxicity plots via linear regression.
2.5. qRT-PCR assay
The qRT-PCR assay procedure was adapted from the study of Shyu et al. with some modifications[21]. HCT-116 and HT-29, to which S. dulcificum extracts showed IC50 activities, were further subjected to qRT-PCR to determine the effect on the expression of the early apoptotic-response genes, c-fos and c-jun. One hundred microliters of each cell line with 1.0 × 105 viable cells/mL were separately placed into 96-well plates (1.0 × 104 cells/well), and incubated for 24 h to allow cell attachment and monolayer formation. Thereafter, each cancer cell line was exposed to 0.2% DMSO (vehicle control), bleomycin (positive control), and corresponding extracts of S. dulcificum which were cytotoxic to the cell lines using their IC50 concentrations. Treatment exposure was done for 30 min. Untreated cancer cell lines were used as negative controls.
Total RNA was then extracted from the cells by using TriZol® reagent (Invitrogen, USA). A final volume of 10 μL reaction was prepared containing 1 χ KAPA SYBR FAST One-Step (KAPA Biosystems, USA), 0.3 μΜ of each forward and reverse primers, and 1 μL of extracted RNA template. Separate reactions were performed for c-fos and c-jun respectively, using the following primers[22],[23]: c-fos forward (5'-AAGGAGAATCC GAAGGGAAAGGAATAAGATGGCT-3') and c-fos reverse (5' -AGACGAAGGAAGACGTGTAAGCAGTGCAGCT-3’ ) with the expected product size of 612 bp; c-jun forward (5’- GCATGAGGAACCGCATTGCCGCCTCCAAGT-3’) and c-jun reverse (5’-GCGACCAAGTCCTTCCCACRCGTGCACACT-3’) with the expected product size of 409 bp. Simultaneously, amplified human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA at standard known concentrations of 109, 108, 107, 106 and 105 were used as standards. All qRT-PCR reactions were conducted by using the Rotor Gene thermocycler (Rotor Gene 3000 and Rotor Gene Q5-Plex HRM) which was programmed to run initial cDNA synthesis at 50 °C for 3 min, followed by 45 cycles of cDNA amplification (denaturation at 95 °C for 20 s, annealing at 55 °C for 30 s, and extension at 72 °C for 35 s). Melting analysis was set at 1 min increment from 72 °C to 95 °C to check and confirm PCR product specificity. Critical cycle thresholds (Ct) were automatically determined by using the built-in Rotor Gene software (RGQ v. 2.3.1.49.).
2.6. Statistical analysis
Student's t-test was performed to determine the statistical differences between the test reactions and controls. Data were presented as mean±SEM and probability value less than 0.05 (P<0.05) was considered significant.
| 3. Results | | |
3.1. Cytotoxicity assay
Stem, leaf, and berry extracts of S. dulcificum were tested for their cytotoxicity on 4 cell lines, namely: HCT-116, HT-29, THP-1, and HDFn. [Figure 1] shows the cytotoxicity graphs of the respective cell lines. When the extract concentration that was cytotoxic to at least 50% of the cells (IC50) was higher than 100 μg/mL, the extract was considered non-cytotoxic[24],[25]. The results showed that the extracts exhibited cytotoxicity in a concentration-dependent manner. | Figure 1: Cytotoxicity graphs for (a) HCT 116, (b) HT 29, (c) THP 1 and (d) HDFn after a week exposure to respective extracts of S. dulcificum and bleomycin.
Click here to view |
Stem methanol extract (Stem MeOH), stem ethanol extract (Stem EtOH), and berry ethanol extract (Berry EtOH) exhibited cytotoxicity on HCT-116 and HT-29, while leaf methanol extract (Leaf MeOH), berry methanol extract (Berry MeOH), and leaf ethanol extract (Leaf EtOH) were non-cytotoxic. None of the extracts were cytotoxic to THP-1 leukemia cell line and the normal human dermal fibroblast HDFn. Similarly, vehicle control (0.2% DMSO in complete DMEM) showed non-cytotoxicity to all tested cell lines (data were not shown). Positive control bleomycin was cytotoxic to all tested cell lines. Plant extracts that showed cytotoxicity were then calculated for their respective IC50 values by plotting respective linear regressions.
For HCT-116, IC50 values of stem MeOH, stem EtOH, berry EtOH, and bleomycin were 49.45 μg/mL, 44.19 μg/mL, 54.37 μg/ mL, and 33.58 μg/mL, respectively. Statistical analysis showed that IC50 values of stem MeOH, stem EtOH, berry EtOH were not significantly different from that of bleomycin (P>0.05), indicating similar potencies of the plant extracts compared to bleomycin. Conversely for HT-29, IC50 values of stem MeOH, stem EtOH, berry EtOH, and bleomycin were 63.97 μg/mL, 54.46 μg/mL, 48.11 μg/ mL, and 25.12 μg/mL, respectively. Statistical analysis showed that IC50 values of stem MeOH, stem EtOH, berry EtOH were significantly higher than that of bleomycin (P<0.05), indicating that bleomycin was significantly more cytotoxic than the plant extracts.
3.2. qRT-PCR assay
qRT-PCR assay was performed to quantify the expressed c-fos and c-jun transcripts in HCT-116 and HT-29 colorectal cancer cells treated with the plant extracts using their respective IC50 concentrations which was derived from the cytotoxicity graphs. Melting analysis confirmed that the fluorescent signals of the amplicons in the extracts and bleomycin treated samples were c-fos and c-jun, and were not secondary to primer dimers. [Figure 2] shows the quantified c-fos and c-jun transcripts after the exposure of HCT-116 and HT-29 to stem MeOH, stem EtOH, berry EtOH, bleomycin, and 0.2% DMSO. The results showed that both c-fos and c-jun transcripts expression were significantly up-regulated in both the colorectal cancer cells treated with the three plant extracts and bleomycin compared to the respective untreated cells (P<0.05). Expectedly, no significant up-regulation of transcript expression was observed in both colorectal cancer cell lines treated with 0.2% DMSO vehicle control compared to that of respective untreated controls (P>0.05). | Figure 2: Quantified c-fos transcript copies on (a) HCT-116 and (c) HT-29 and the quantified c-jun on (b) HCT-116 and (d) HT-29. Significant difference (P<0.05) between the extracts and the untreated control is indicated with an asterisk (*).
Click here to view |
| 4. Discussion | | |
The present study showed that stem and berry extracts of S. dulcificum possess anticancer activity against HCT116 and HT29 human colorectal cancer cells, but not on THP-1 leukemia cells and HDFn normal human dermal fibroblasts. It has been known that the S. dulcificum extracts are rich in various amides and monoterpene- sesquiterpene derivatives, which possess antibacterial and anticancer activities[16],[26]. Furthermore, it has been reported that plant-derived phenolics and flavonoids possess anticancer activities on various tumors[27]. S. dulcificum berry and stem were found to have phenolic compounds such as gallic acid, ferulic acid[13], syringic acid, and vanillic acid[15]. Moreover, S. dulcificum berry was found to have flavonoids such as quercetin, myricetin and kaempferol[13], which are known to bring low incidence of colon cancer[27]. However, for unknown reason, berry MeOH failed to induce apoptosis in tested cell lines. This may be due to the different capability of solvents to extract the potent components.
Although several groups have reported that the extracts of S. dulcificum exhibit anticancer activities against various cancer cell lines[14],[15],[16], the molecular mechanism by which the extracts exhibited these effects was not elucidated. Here we showed that stem and berry extracts of S. dulcificum induced apoptosis through upregulation of early apoptotic genes c-fos and c-jun. Several groups have reported that up-regulation of c-fos and c-jun mRNA expression is one of the markers of apoptosis[28],[29],[30],[31]. The proto-oncogenes c-fos and c-jun are immediate-early genes that encode for proteins which form a transcription factor called activator protein-1 (AP-1)[32],[33], which can be in heterodimer form of c-fos and c-jun products or homodimer form of c-jun products[32]. AP-1 is linked to various cell functions such as cell proliferation, differentiation and apoptosis[34]. It has been reported that AP-1 is a crucial element that is needed in the induction of transforming growth factor- β 1, a homodimer protein that induces apoptosis in cancer cells[35]. On the other hand, Shyu et al. assumed that upregulation of c-fos and c-jun transcripts and following apoptosis may be due to the subsequent AP-1 formation and its involvement in mitogen-activated protein kinase pathway or sensitization of the cancer cells to the tumor necrosis factor-related apoptosis-inducing ligand pathway[21]. However, the present study is limited to viewing the upregulation of c-fos and c-jun. Thus, further research on the cellular mechanisms by which the extracts mediate apoptosis needs to be elucidated.
Cytotoxic activity of S. dulcificum extracts were examined in the present study by using the PrestoBlue® resazurin assay. Stem MeOH, stem EtOH and berry EtOH extracts of S. dulcificum were found to be cytotoxic to HCT-116 and HT-29 colorectal cancer cells. The IC50 values of the three plant extracts showed that these were of comparable potencies with bleomycin for HCT-116 cells, but were less potent compared to bleomycin for HT-29 cells. None of the extracts were cytotoxic to THP-1 monocytic leukemia cells and HDFn normal human dermal fibroblasts. The study also revealed that the cytotoxicity of S. dulcificum on HCT-116 and HT-29 was due to the up-regulation of c-fos and c-jun transcript expression, suggesting an early apoptosis mechanism.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Acknowledgements
The authors acknowledge the Molecular Science Unit Laboratory of the Center for Natural Sciences and Ecological Research, De La Salle University, Manila for the cell lines and the use of the laboratory facilities.
| References | | |
| 1. | Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.  |
| 2. | Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65(2): 87-108. |
| 3. | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66(1): 7-30. |
| 4. | Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol 2015; 35: S25-S54. |
| 5. | Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, et al. Broad targeting of resistance to apoptosis in caner. Semin Cancer Biol 2015; 35: S78-S103. |
| 6. | Fulda S. Targeting extrinsic apoptosis in cancer: Challenges and opportunities. Semin Cell Dev Biol 2015; 39: 20-25. |
| 7. | Goldar S, Khaniani MS, Derakhshan SM, Baradaran B. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev 2015; 16(6): 2129-2144. |
| 8. | Koff JL, Ramachandiran S, Bernal-Mizrachi L. A time to kill: Targeting apoptosis in cancer. Int J Mole Sci 2015; 16(2): 2942-2955. |
| 9. | Safarzadeh E, Shotorbani SS, Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull 2014; 4(Suppl 1): 421-427. |
| 10. | Brouwer JN, Van Der Wel H, Francke H, Henning GJ. Miraculin, the sweetness-inducing protein from Miracle fruit. Nature 1968; 220: 373-374. |
| 11. | Kurihara K, Beidler LM. Mechanism of the action of the taste-modifying protein. Nature 1969; 222: 1176. |
| 12. | Lim TK. Edible medicinal and non-medical plants. Berlin: Springer Science & Business Media; 2012. |
| 13. | Du LQ, Shen YX, Zhang XM, Prinyawiwatkul W, Xu ZM. Antioxidant- rich phytochemicals in miracle berry (Synsepalum dulcificum) and antioxidant activity of its extracts. Food Chem 2014; 153: 279-284. |
| 14. | Chen TY, Kang ZC, Yen MT, Huang MH, Wang BS. Inhibitory effect of aqueous extracts from Miracle Fruit leaves on mutation and oxidative damage. Food Chem 2015; 169: 411-416. |
| 15. | Wang HM, Chou YT, Hong ZL, Chen HA, Chang YC, Yang WL, et al. Bioconstituents from stems of Synsepalum dulcificum Daniell (Sapotaceae) inhibit human melanoma proliferation, reduce mushroom tyrosinase activity and have antioxidant properties. J Taiwan Inst Chem E 2011; 42(2): 204-211. |
| 16. | Lu SL, Liu H, Chen GY, Han CR, Zang WX. Chemical composition of leaf essential oil of Synsepalum dulcificum and evaluation of its antibacterial and antitumoral activities in vitro. Chem Ind Forest Prod 2014; 34: 121-127. |
| 17. | Chen CY, Wang YD, Wang HM. Chemical constituents from the leaves of Synsepalum dulcificum. Chem Nat Compd 2010; 46: 495. |
| 18. | Chen CY, Wang YD, Wang HM. Chemical constituents from the roots of Synsepalum dulcificum. Chem Nat Compd 2010; 46: 448-449. |
| 19. | Cheng MJ, Hong ZL, Chen CY. Secondary metabolites from the stems of Synsepalum dulcificum. Chem Nat Compd 2012; 48: 108-109. |
| 20. | Rezaei A, Oyong GG, Borja VB, Inoue M, Abe T, Tamamnura R, et al. Molecular screening of anti-quorum sensing capapbility of Salvadora persica on Enterococcus faecalis. J Hard Tissue Biol 2011; 20: 115-124. |
| 21. | Shyu PT, Oyong GG, Cabrera EC. Cytotoxicity of probiotics from Philippine commercial dairy products on cancer cells and the effect on expression of cfos and cjun early apoptotic-promoting genes and Interleukin-1 β and Tumor Necrosis Factor- α proinflammatory cytokine genes. Biomed Res Int 2014; 2014: 491740. |
| 22. | Huang FM, Chou MY, Chang YC. Dentin bonding agents induce c-fos and c-jun protooncogenes expression in human gingival fibroblast. Biomaterials 2003; 24: 157-163. |
| 23. | Garrett SH, Phillips V, Somji S, Sens MA, Dutta R, Park S, et al. Transient induction of metallothionein isoform 3 (MT-3), c-fos, c-jun and c-myc in human proximal tubule cells exposed to cadmium. Toxicol Lett 2002; 126(1): 69-80. |
| 24. | Galea J, Armstrong J, Francis SE, Cooper G, Crossman DC, Holt CM. Alteration in c-fos expression, cell proliferation and apoptosis in pressure distended human saphenous vein. Cardiovasc Res 1999; 44(2): 436-448. |
| 25. | Chicca A, Pellati F, Adinolifi B, Matthias A, Massarelli I, Benvenuti S, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. Br J Pharmacol 2008; 153(5): 879-885. |
| 26. | Swamy KB, Hadi SA, Sekaran M, Pichika MR. The clinical effects of Synsepalum dulcificum: A review. J Med Food 2014; 17(11): 1165-1169. |
| 27. | Safarzadeh E, Shotorbani SS, Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull 2014; 4: 421-427. |
| 28. | Tormos C, Chaves FJ, Garcia MJ, Garrido F, Jover R, O’Connor JE, et al. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNA by oxidative stress in tumor cells. Cancer Lett 2004; 208(1): 103-113. |
| 29. | Santos MM, Tannuri ACA, Coelho MCM, Goncalves JO, Serafini S, Silva LFF, et al. Immediate expression of c-fos and c-jun mRNA in a model of intestinal autotransplantation and ischemia reperfusion in situ. Clinics 2015; 70(5): 373-379. |
| 30. | Chueh AC, Tse JWT, Dickinson M, Ioannidis P, Jenkins L, Togel L, et al. ATF3 repression of BCL-XL determines apoptotic sensitivity to HDAC inhibitors across tumor types. Clin Cancer Res 2017; 23(18). DOI: 10.1158/1078-0432. |
| 31. | Tsai CY, Chen YH, Chien YW, Huang WH, Lin SH. Effect of soy saponin on the growth of human colon cancer cells. World J Gastroenterol 2010; 16(27): 3371-3376. |
| 32. | Papoudou-Bai A, Hatzimichael E, Barbouti A, Kanavaros P. Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms. Clin Expt Med 2017; 17(3): 291-304. |
| 33. | Bahrami S, Drablos F. Gene regulation in the immediate-early response process. Adv Biol Regul 2016; 62: 37-49. |
| 34. | Ameyar M, Wisniewska M, Weitzman JB. A role for AP-1 in apoptosis: The case for and case against. Biochimie 2003; 85(8): 747-752. |
| 35. | Yamamura Y, Hua X, Bergelson S, Lodish HF. Critical role of Smad and AP-1 complex in transforming growth factor- β -dependent apoptosis. J Biol Chem 2000; 275(46): 36295-36302. |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
Triterpenoids from the leaves of Synsepalum dulcificum and their antitumor activities against hepatocellular carcinoma cells |
|
| Qing Tang, Xiao-Yong Dai, Zhao-Chun Zhan, Yi-Kun Hao, Jin-Lin Tan, Hai-Yue Zhao, Yibo Hou, Wen-Sheng Xuan, Yao-lan Li, Lai-Qiang Huang, Guo-Cai Wang, Yu-Bo Zhang | | Industrial Crops and Products. 2023; 193: 116155 | | [Pubmed] | [DOI] | | | 2 |
Antimicrobial secondary metabolites from an endophytic fungus Aspergillus polyporicola |
|
| Si-Si Liu, Rong Huang, Shou-Peng Zhang, Tang-Chang Xu, Kun Hu, Shao-Hua Wu | | Fitoterapia. 2022; 162: 105297 | | [Pubmed] | [DOI] | | | 3 |
Mechanism of Synsepalum dulcificum Daniell. Inhibiting Lung Adenocarcinoma |
|
| Qi Chen, Tingting Liu, Tuya Bai, Mengdi Zhang, Yuxia Hu, Jun Li, Fuhou Chang, Siyaram Pandey | | Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 1 | | [Pubmed] | [DOI] | | | 4 |
Identification of phenolics from miracle berry (Synsepalum dulcificum) leaf extract and its antiangiogenesis and anticancer activities |
|
| Fei-Yue Ma, Xiu-Mei Zhang, Ya Li, Ming Zhang, Xing-Hao Tu, Li-Qing Du | | Frontiers in Nutrition. 2022; 9 | | [Pubmed] | [DOI] | | | 5 |
Integrated miRNA and mRNA omics reveal the anti-cancerous mechanism of Licochalcone B on Human Hepatoma Cell HepG2 |
|
| Jun Wang,Chu-yan Wang | | Food and Chemical Toxicology. 2021; : 112096 | | [Pubmed] | [DOI] | | | 6 |
The cholesterol-lowering activity of miracle fruit (
Synsepalum dulcificum
) |
|
| Weihuan Huang,Hau Yin Chung,Wensheng Xuan,Guocai Wang,Yaolan Li | | Journal of Food Biochemistry. 2020; | | [Pubmed] | [DOI] | | | 7 |
Nutritional benefits, phytochemical constituents, ethnomedicinal uses and biological properties of Miracle fruit plant (Synsepalum dulcificum Shumach. & Thonn. Daniell) |
|
| Afolabi Clement Akinmoladun,Aanuoluwapo Ruth Adetuyi,Kayode Komolafe,Oluwafemi Omoniyi Oguntibeju | | Heliyon. 2020; 6(12): e05837 | | [Pubmed] | [DOI] | | | 8 |
Phytochemical screening, antioxidant, anti-diabetic and cytotoxic activity of leaves of Pandanus canaranus Warb |
|
| Venkatachalam Balamurugan,Kannan Raja,Subramaniam Selvakumar,Krishnan Vasanth | | Materials Today: Proceedings. 2020; | | [Pubmed] | [DOI] | | | 9 |
Miracle Berry as a Potential Supplement in the Control of Metabolic Risk Factors in Cancer |
|
| Marta Gómez de Cedrón,Sonia Wagner,Marina Reguero,Adrián Menéndez-Rey,Ana Ramírez de Molina | | Antioxidants. 2020; 9(12): 1282 | | [Pubmed] | [DOI] | | | 10 |
Licochalcone B Extracted from Glycyrrhiza uralensis Fisch Induces Apoptotic Effects in Human Hepatoma Cell HepG2 |
|
| Jun Wang,Ai-Mei Liao,Kiran Thakur,Jian-Guo Zhang,Ji-Hong Huang,Zhao-Jun Wei | | Journal of Agricultural and Food Chemistry. 2019; | | [Pubmed] | [DOI] | | | 11 |
Preparation, structure identification and the anti-photoaging activity of peptide fraction OP-Ia from Ostrea rivularis |
|
| Yuhui Ye,Lijun You,Qihui Deng,Xiong Li,Mouming Zhao | | RSC Advances. 2019; 9(1): 44 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for